BridgeBio Oncology Therapeutics, Inc. (BBOT) › Cash & EquivalentsBridgeBio Oncology Therapeutics, Inc. (BBOT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2024: $30.85M2025: $373.69M$373.69M2024Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$373.69M+1111.3%2024$30.85M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share